The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: A randomised controlled study

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Kim, Sang Wook ^a   Ha, Ki Chan ^b,c   Choi, Eun Kyung ^a   Jung, Su Young ^a   Kim, Min Gul ^a   Kwon, Dae Young ^d   Yang, Hye Jung ^d   Kim, Min Jung ^d   Kang, Hee Joo ^d   Back, Hyang Im ^b,c   Kim, Sun Young ^a,b   Park, Soo Hyun ^a   Baek, Hum Young ^e   Kim, Yong Jae ^e   Lee, Joon Yeol ^e   Chae, Soo Wan ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

^c Healthcare Claims and Management   (South Korea)

^d Korea Food Research Institute   (South Korea)

^e Korea INS Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; PLACEBO; TURMERIC;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; LIPID BLOOD LEVEL; LIVER FUNCTION; LIVER PROTECTION; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CURCUMA; DOUBLE-BLIND METHOD; FEMALE; FERMENTATION; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 84874671306     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-58     Document Type: Article

References (35)

1. Reddy B, Kokate C, Rambhau D, Venkateshwarlu V, Murthy V. Antihepatotoxic activity of some ayurvedic preparations. Indian J Pharm Sci 1993, 55(4):137-140.
2. Rao GM, Rao CV, Pushpangadan P, Shirwaikar A. Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. J Ethnopharmacol 2006, 103(3):484-490. 10.1016/j.jep.2005.08.073, 16213120.
3. Zeashan H, Amresh G, Singh S, Rao CV. Hepatoprotective activity of Amaranthus spinosus in experimental animals. Food Chem Toxicol 2008, 46(11):3417-3421. 10.1016/j.fct.2008.08.013, 18783728.
4. Sunilson J, Anbu J, Jayaraj P, Syam Mohan M, Anita Gnana Kumari A, Varatharajan R. Antioxidant and hepatoprotective effect of the roots of Hibiscus esculentus Linn. Int J Green Pharm 2008, 2(4):200-203.
5. Tandon VR, Khajuria V, Kapoor B, Kour D, Gupta S. Hepatoprotective activity of Vitex negundo leaf extract against anti-tubercular drugs induced hepatotoxicity. Fitoterapia 2008, 79(7-8):533-538.
6. Sunilson J, Muthappan M, Das A, Suraj R. Hepatoprotective activity of Coccinia grandis leaves against carbon tetrachloride induced hepatic injury in rats. International J Pharmacol 2009, 5:222-227.
7. Deshpande UR, Gadre SG, Raste AS, Pillai D, Bhide SV, Samuel AM. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats. Indian J Exp Biol 1998, 36(6):573-577.
8. Adaramoye OA, Odunewu AO, Farombi EO. Hepatoprotective effect of Curcuma longa L. in D-galactosamine induced liver injury in mice: evidence of antioxidant activity. Afr J Med Med Sci 2010, 39 Suppl:27-34.
9. Miyakoshi M, Yamaguchi Y, Takagaki R, Mizutani K, Kambara T, Ikeda T, Zaman MS, Kakihara H, Takenaka A, Igarashi K. Hepatoprotective effect of sesquiterpenes in turmeric. Biofactors 2004, 21(1-4):167-170.
10. El-Shahat M, El-Abd S, Alkafafy M, El-Khatib G. Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: Myrrh (Commiphora molmol) vs. turmeric (Curcuma longa). Acta Histochem 2012, 114(5):421-428. 10.1016/j.acthis.2011.08.002, 21871653.
11. Cerny D, Lekic N, Vanova K, Muchova L, Horinek A, Kmonickova E, Zidek Z, Kamenikova L, Farghali H. Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: relationship to HO-1/CO antioxidant system. Fitoterapia 2011, 82(5):786-791. 10.1016/j.fitote.2011.04.003, 21545828.
12. Bao W, Li K, Rong S, Yao P, Hao L, Ying C, Zhang X, Nussler A, Liu L. Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. J Ethnopharmacol 2010, 128(2):549-553. 10.1016/j.jep.2010.01.029, 20080166.
13. Park SH, Lim H, Hwang S. Evaluation of antioxidant, rheological, physical and sensorial properties of wheat flour dough and cake containing turmeric powder. Food Sci Technol Int 2012, 18(5):435-443. 10.1177/1082013211428220, 23144239.
14. Tonnesen HH. Studies on curcumin and curcuminoids. XV. Catalytic effect of demethoxy- and bisdemethoxycurcumin on the peroxidation of linoleic acid by 15-lipoxygenase. Int J Pharm 1989, 51(2):179-181.
15. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol 2007, 595:471-480. 10.1007/978-0-387-46401-5_21, 17569225.
16. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976, 25(15):1811-1812. 10.1016/0006-2952(76)90421-4, 942483.
17. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999, 39(1):41-47. 10.1006/phrs.1998.0404, 10051376.
18. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001, 21(4B):2895-2900.
19. Shapiro H, Ashkenazi M, Weizman N, Shahmurov M, Aeed H, Bruck R. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. J Gastroenterol Hepatol 2006, 21(2):358-366. 10.1111/j.1440-1746.2005.03984.x, 16509859.
20. Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int 2007, 27(3):373-383. 10.1111/j.1478-3231.2007.01453.x, 17355460.
21. Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000, 52(4):437-440. 10.1211/0022357001774048, 10813555.
22. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 2007, 1770(6):989-996. 10.1016/j.bbagen.2007.02.004, 17383825.
23. Kim YJ, You YH, Jun WJ. Hepatoprotective activity of fermented Curcuma longa L. on galactosamine-intoxicated rats. J Korean Soc Food Sci Nutr 2012, 41(6):790-795.
24. Lee HS, Li L, Kim HK, Bilehal D, Li W, Lee DS, Kim YH. The protective effects of Curcuma longa Linn. Extract on carbon tetrachloride-induced hepatotoxicity in rats via upregulation of Nrf2. J Microbiol Biotechnol 2010, 20(9):1331-1338. 10.4014/jmb.1002.03010, 20890099.
25. Song EK, Cho H, Kim JS, Kim NY, An NH, Kim JA, Lee SH, Kim YC. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med 2001, 67(9):876-877. 10.1055/s-2001-18860, 11745031.
26. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 2002, 34(1):37-46. 10.1016/S0167-4943(01)00194-7, 14764309.
27. Das KC, Das CK. Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem Biophys Res Commun 2002, 295(1):62-66. 10.1016/S0006-291X(02)00633-2, 12083767.
28. Ak T, Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008, 174(1):27-37. 10.1016/j.cbi.2008.05.003, 18547552.
29. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995, 206(2):533-540. 10.1006/bbrc.1995.1076, 7530002.
30. Kim JE, Kim AR, Chung HY, Han SY, Kim BS, Choi JS. In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa. Phytother Res 2003, 17(5):481-484. 10.1002/ptr.1179, 12748983.
31. Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 2003, 92(1):33-38. 10.1034/j.1600-0773.2003.920106.x, 12710595.
32. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000, 28(8):1303-1312. 10.1016/S0891-5849(00)00294-X, 10889462.
33. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995, 270(42):24995-25000. 10.1074/jbc.270.42.24995, 7559628.
34. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 2003, 284(2):G321-327.
35. Kang JK, Kang HJ, Seo JH, Kim SO, Choi JH, Cho DY, Park CG, Lee HY. Effects of fermented turmeric (Curcuma longa) by Bacillus natto supplementation on liver function and serum lipid parameters in mice. J Korean Soc Food Sci Nutr 2009, 38:430-435.